1-3 of 3
Stefano Manzini
Close
Sort by
Journal Articles

MEN1112/OBT357, an Anti Bst1/CD157 Humanized Antibody Inducing Acute Myelogenous Leukemia (AML) Blast Depletion in an Autologous Ex Vivo Assay: A Potential New Targeted Therapy for AML

Adriano Venditti, MD, Francesco Buccisano, Luca Maurillo, MD, Maria Ilaria Del Principe, MD, Andrea Coppola, Patrizia Palomba, Roberto Arriga, Daniela Bellarosa, Alessandro Bressan, Keith Wilson, Stefano Manzini, Angela Capriati, MD PhD, Cecilia Simonelli, MD, Monica Binaschi, Sergio Amadori, MD, Giuseppe Sconocchia
Journal: Blood
Blood (2015) 126 (23): 788.
https://doi.org/10.1182/blood.V126.23.788.788
Published: 2015
Journal Articles

MEN1112, a Novel Humanized De-Fucosylated Monoclonal Antibody with High Affinity and Specificity for Bst1/CD157 Antigen and Enhanced CD16 Binding

Dee Aud, Rachel Dusek, PhD, Arnima Bisht, PhD, Sudha Swaminithan, Rahel Awdew, Michael Trang, San Lin Lou, Stefano Manzini, Alfredo Martinez Mogarra, Alessandro Bressan, Jon Terrett, PhD, Monica Binaschi
Journal: Blood
Blood (2014) 124 (21): 3607.
https://doi.org/10.1182/blood.V124.21.3607.3607
Published: 2014
Journal Articles

Targeting and Depletion of Acute Myeloid Leukemia Blasts By MEN1112, a Novel Humanized Defucosylated Monoclonal Antibodies with Specificity for Bst1/CD157 Antigen

Adriano Venditti, Francesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, Andrea Coppola, Patrizia Palomba, Anna Aureli, Roberto Arriga, Daniela Bellarosa, Alessandro Bressan, Stefano Manzini, Cecilia Simonelli, Monica Binaschi, Sergio Amadori, Giuseppe Sconocchia
Journal: Blood
Blood (2014) 124 (21): 2235.
https://doi.org/10.1182/blood.V124.21.2235.2235
Published: 2014